|
1.
|
|
8 p, 535.7 KB |
Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib
/
Joensuu, Heikki (Helsinki University Hospital) ;
Blay, Jean-Yves (University Claude Bernard Lyon I) ;
Comandone, Alessandro (Gradenigo Hospital) ;
Martin-Broto, Javier (Hosp o Virgen del Rocío (Sevilla, Andalusia)) ;
Fumagalli, Elena (Fondazione IRCCS Istituto Nazionale Dei Tumori) ;
Grignani, Giovanni (Candiolo Cancer Institute. FPO - IRCCS) ;
Del Muro, Xavier Garcia (Hospital Universitari de Bellvitge) ;
Adenis, Antoine (Centre Oscar Lambret) ;
Valverde, Claudia (Hospital Universitari Vall d'Hebron) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Bouche, Olivier (University Hospital Robert Debre) ;
Italiano, Antoine (Comprehensive Cancer Centre. 2Institut Bergonie) ;
Bauer, Sebastian (University of Duisburg- Essen) ;
Barone, Carlo (University Hospital A. Gemelli) ;
Weiss, Claudia (Novartis Pharma GmbH) ;
Crippa, Stefania (Novartis Farma) ;
Camozzi, Maura (Novartis Farma) ;
Castellana, Ramon (Novartis Farmaceutica SA) ;
Le Cesne, Axel (Gustave Roussy) ;
Universitat Autònoma de Barcelona
This multicentre phase II trial (DOVIGIST) evaluated the antitumour activity of dovitinib as second-line treatment of patients with gastrointestinal stromal tumour (GIST) refractory to imatinib or who do not tolerate imatinib. [...]
2017 -  10.1038/bjc.2017.290
British Journal of Cancer, Vol. 117 Núm. 9 (2017) , p. 1278-1285
|
|
|
2.
|
|
17 p, 345.4 KB |
Bone sarcomas : ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
/
Casali, P.G. (University of Milan) ;
Bielack, Stefan S (Klinikum Stuttgart-Olgahospital) ;
Abecassis, N. (Instituto Portugues de Oncologia de Lisboa Francisco Gentil EPE) ;
Aro, H.T. (Turku University Hospital (Turun Yliopistollinen Keskussairaala)) ;
Bauer, S. (University Hospital Essen (Alemanya)) ;
Biagini, Roberto (Regina Elena National Cancer Institute) ;
Bonvalot, S. (Institut Curie) ;
Boukovinas, I. (Bioclinic Thessaloniki) ;
Bovee, J.V.M.G. (Leiden University Medical Center) ;
Brennan, B. (Royal Manchester Children's Hospital) ;
Brodowicz, Thomas (Medizinische Universität Wien) ;
Broto, J.M. (Hospital Universitario Virgen Del Rocio-CIBERONC) ;
Brugières, L. (Gustave Roussy Cancer Campus) ;
Buonadonna, A. (Centro di Riferimento Oncologico di Aviano) ;
De Alava, E (Universidad de Sevilla) ;
Dei Tos, A.P. (Ospedale Regionale di Treviso S.Maria di Cà Foncello) ;
Del Muro, X.G. (Integrated Unit ICO Hospitalet) ;
Dileo, P. (University College London Hospitals NHS Trust) ;
Dhooge, C. (Universitair Ziekenhuis Gent) ;
Eriksson, M. (Skåne University Hospital (Suècia)) ;
Fagioli, F. (University of Turin) ;
Fedenko, A. (N. N. Blokhin Russian Cancer Research Center) ;
Ferraresi, V. (Regina Elena National Cancer Institute) ;
Ferrari, A. (Fondazione IRCCS Istituto Nazionale Dei Tumori) ;
Ferrari, S. (Istituto Ortopedico Rizzoli) ;
Frezza, A.M. (Istituto Nazionale Dei Tumori) ;
Gaspar, N. (Gustave Roussy Cancer Campus) ;
Gasperoni, S. (Azienda Ospedaliera Universitaria Careggi Firenze) ;
Gelderblom, H. (Leiden University Medical Centre) ;
Gil, T. (Institut Jules Bordet) ;
Grignani, G. (Candiolo Cancer Institute) ;
Gronchi, A. (University of Milan) ;
Haas, R.L. (Leiden University Medical Centre) ;
Hassan, B. (Oxford University Hospitals NHS Foundation Trust) ;
Hecker-Nolting, S. (Klinikum Stuttgart-Olgahospital) ;
Hohenberger, P. (Mannheim University Medical Center) ;
Issels, R. (University Munich) ;
Joensuu, H. (Helsinki University Central Hospital (HUCH)) ;
Jones, R.L. (Royal Marsden Hospital (Regne Unit)) ;
Judson, I. (Institute of Cancer Research) ;
Jutte, P. (University Medical Center Groningen) ;
Kaal, S. (Radboud University Medical Center) ;
Kager, L. (St. Medical University Vienna) ;
Kasper, B. (Mannheim University Medical Center) ;
Kopeckova, K. (University Hospital Motol) ;
Krákorová, D.A. (Masaryk Memorial Cancer Institute) ;
Ladenstein, R. (Medical University Vienna) ;
Le Cesne, A. (Gustave Roussy Cancer Campus) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Lugowska, I. (Maria Skłodowska Curie Institute-Oncology Centre) ;
Merimsky, O. (Tel Aviv Sourasky Medical Center (Ichilov)) ;
Montemurro, M. (Medical Oncology University Hospital of Lausanne) ;
Morland, B. (Birmingham Women's and Children's NHS Foundation Trust) ;
Pantaleo, M.A. (Policlinico S Orsola-Malpighi Università di Bologna) ;
Piana, R. (University of Turin) ;
Picci, P. (Istituto Ortopedico Rizzoli) ;
Piperno-Neumann, S. (Institut Curie) ;
Reichardt, P. (Helios Klinikum Berlin Buch) ;
Robinson, M.H. (Weston Park Hospital NHS Trust) ;
Rutkowski, P. (Maria Skłodowska Curie Institute-Oncology Centre) ;
Safwat, A.A. (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Schöffski, P. (University Hospitals Leuven (Bèlgica)) ;
Sleijfer, S. (Erasmus MC Cancer Institute) ;
Stacchiotti, S. (Istituto Nazionale Dei Tumori) ;
Strauss, S.J. (University College London Hospitals NHS Trust) ;
Sundby Hall, K. (Norwegian Radium Hospital) ;
Unk, M. (Institute of Oncology of Ljubljana) ;
Van Coevorden, F. (Netherlands Cancer Institute Antoni Van Leeuwenhoek) ;
Van Der Graaf, W.T.A. (Netherlands Cancer Institute Antoni Van Leeuwenhoek) ;
Whelan, J. (Sarcoma Unit. University College London Hospitals NHS Trust) ;
Wardelmann, E. (Universitätsklinikum Münster) ;
Zaikova, O. (Oslo University Hospital (Oslo, Noruega)) ;
Blay, Jean-Yves (Centre Leon Bernard and UCBL1) ;
Universitat Autònoma de Barcelona
2018 - 10.1093/annonc/mdy310
Annals of oncology, Vol. 29 (january 2018) , p. iv79-iv95
|
|
|
3.
|
|
12 p, 506.4 KB |
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
/
Stein, Eytan M. (Memorial Sloan Kettering Cancer Center (New York)) ;
DeAngelo, Daniel J. (Dana-Farber Cancer Institute (Boston, Massachusetts)) ;
Chromik, Jörg (Goethe University Frankfurt) ;
Chatterjee, Manik (University Hospital of Würzburg) ;
Bauer, Sebastian (German Consortium of Translational Cancer Research (DKTK)) ;
Lin, Chia-Chi (National Taiwan University Hospital (Taipei, Taiwan)) ;
Suárez, Cristina (Vall d'Hebron Institut d'Oncologia) ;
de Vos, Filip (University Medical Center Utrecht) ;
Steeghs, Neeltje (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
Cassier, Philippe A. (Léon Bérard Center) ;
Tai, David (National Cancer Center Singapore) ;
Kiladjian, Jean-Jacques (Université de Paris) ;
Yamamoto, Noboru (National Cancer Center Hospital (Tokyo, Japó)) ;
Mous, Rogier (University Medical Center Utrecht) ;
Esteve Reyner, Jordi (Hospital Clínic i Provincial de Barcelona) ;
Minami, Hironobu (Kobe University Graduate School of Medicine and Hospital (Japó)) ;
Ferretti, Stephane (Novartis Institutes for Biomedical Research) ;
Guerreiro, Nelson (Novartis Institutes for Biomedical Research) ;
Meille, Christophe (Novartis Institutes for Biomedical Research) ;
Radhakrishnan, Rajkumar (Novartis Healthcare Private Limited (Hyderabad, India)) ;
Pereira, Bernard (Novartis Institutes for BioMedical Research (Cambridge, Massachusetts)) ;
Mariconti, Luisa (Novartis Institutes for Biomedical Research) ;
Halilovic, Ensar (Novartis Institutes for BioMedical Research (Cambridge, Massachusetts)) ;
Fabre, Claire (Novartis Institutes for Biomedical Research) ;
Carpio Segura, Cecilia del Carmen (Vall d'Hebron Institut d'Oncologia) ;
Universitat Autònoma de Barcelona
This phase I, dose-escalation study investigated the recommended dose for expansion (RDE) of siremadlin, a p53-MDM2 inhibitor, in patients with wild-type TP53 advanced solid or hematologic cancers. Initial dosing regimens were: 1A (day 1; 21-day cycle; dose 12. [...]
2021 - 10.1158/1078-0432.CCR-21-1295
Clinical Cancer Research, Vol. 28 (december 2021) , p. 870-881
|
|
|
4.
|
|
11 p, 900.3 KB |
Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors
/
Lewis, James H. (MedStar Georgetown University Hospital) ;
Gelderblom, Hans J (Leiden University Medical Center) ;
van de Sande, Michiel (Leiden University Medical Center (Països Baixos)) ;
Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Healey, John H. (Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College (Nova York, Estats Units d'Amèrica)) ;
Tap, William D. (Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College (Nova York, Estats Units d'Amèrica)) ;
Wagner, Andrew J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Druta, Mihaela (Moffitt Cancer Center (Tampa, Florida)) ;
Lin, ChiaChi Chi Josh (National Taiwan University Hospital (Taipei, Taiwan)) ;
Baba, Hideo Andreas (University Hospital Essen (Alemanya)) ;
Choi, Youngsook (Daiichi Sankyo. Inc (Nova Jersey, Estats Units)) ;
Wang, Qiang (Daiichi Sankyo. Inc (Estats Units)) ;
Shuster, Dale E. (Daiichi Sankyo. Inc (Estats Units))) ;
Bauer, Sebastian (University of Duisburg-Essen (Alemanya))
Background: Pexidartinib is approved in the U. S. for tenosynovial giant cell tumors (TGCTs). Herein, we assessed the hepatic safety profile of pexidartinib across patients with TGCTs receiving pexidartinib. [...]
2021 - 10.1002/onco.13629
The Oncologist, Vol. 26 Núm. 5 (may 2021) , p. e863-e873
|
|
|
5.
|
|
14 p, 2.6 MB |
Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts
/
Stacchiotti, Silvia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Miah, Aisha B. (The Royal Marsden Hospital) ;
Frezza, Anna Maria (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Messiou, Christina (Department of Radiology. The Royal Marsden Hospital and The Institute of Cancer Research) ;
Morosi, Carlo (Radiology Department. Fondazione IRCCS Istituto Nazionale Tumori) ;
Caraceni, Augusto (Fondazione IRCCS Istituto Nazionale Tumori) ;
Antonescu, Cristina (Memorial Sloan Kettering Cancer Center) ;
Bajpai, Jyoti (Homi Bhabha National Institute. Medical Oncology Department) ;
Baldini, Elizabeth Healey (Dana-Farber Cancer Center/Brigham) ;
Bauer, Sebastian (University of Duisburg-Essen) ;
Biagini, Roberto (Regina Elena National Cancer Institute) ;
Bielack, Stefan S. (Klinikum Stuttgart - Olgahospital) ;
Blay, Jean-Yves (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ;
Bonvalot, Sylvie (Institut Curie. Department of Surgical Oncology) ;
Boukovinas, Ioannis P. (Nordix) ;
Bovee, Judith V.M.G. (Leiden University Medical Center) ;
Boye, Kjetil (The Norwegian Radium Hospital) ;
Brodowicz, Thomas (Medical University Vienna) ;
Callegaro, Dario (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
De Álava, Enrique (Department of Normal and Pathological Cytology and Histology. School of Medicine. University of Seville) ;
Deoras-Sutliff, M. (The EHE Foundation) ;
Dufresne, Armelle (Department of Medical Oncology. Centre Leon Berard. Université Claude Bernard Lyon. Unicancer) ;
Eriksson, Mikael (Department of Oncology. Skane University Hospital and Lund University) ;
Errani, Costantino (Orthopaedic Service. Musculoskeletal Oncology Department. IRCCS Istituto Ortopedico Rizzoli) ;
Fedenko, Alexander (Medical Oncology Division. P.A. Herzen Cancer Research Institute) ;
Ferraresi, Virginia (Sarcomas and Rare Tumors Unit. IRCCS Regina Elena National Cancer Institute) ;
Ferrari, Andrea (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Fletcher, Christopher D.M. (Department of Pathology Brigham & Women's Hospital) ;
Garcia del Muro, Xavier (Universitat de Barcelona) ;
Gelderblom, Hans J. (Department of Medical Oncology. Leiden University Medical Center) ;
Gladdy, Rebecca A. (University of Toronto and Lunenfeld-Tanenbaum Research Institute) ;
Gouin, François (Department of Surgery. Centre Leon Berard) ;
Grignani, Giovanni (Candiolo Cancer Institute. FPO - IRCCS) ;
Gutkovich, J. (NUY Langone Medical Center) ;
Haas, Rick (Department of Radiotherapy. the Leiden University Medical Center) ;
Hindi, Nadia (Universidad de Sevilla. Instituto de Biomedicina de Sevilla) ;
Hohenberger, Peter (Mannheim University Medical Center) ;
Huang, Paul (Division of Molecular Pathology. The Institute of Cancer Research) ;
Joensuu, Heikki T. (Department of Oncology. Helsinki University Hospital & Helsinki University) ;
Jones, Robin Lewis (Department of Cancer. The Royal Marsden Hospital and The Institute of Cancer Research) ;
Jungels, Christiane (Institut Jules Bordet. Université Libre de Bruxelles) ;
Kasper, Bernd (University of Heidelberg. Mannheim University Medical Center. Sarcoma Unit) ;
Kawai, Akira (Musculoskeletal Oncology and Rehabilitation Medicine. Rare Cancer Center National Cancer Center Hospital) ;
Le Cesne, Axel (International Department. Gustave Roussy) ;
Le Grange, Franél (UCLH - University College London Hospitals NHS Foundation Trust) ;
Leithner, Andeas (Department of Orthopaedics and Trauma Medical University Graz) ;
Leonard, H. (Chair of Trustees of the EHE Rare Cancer Charity (UK). Charity number 1162472) ;
López Pousa, Antonio (Institut d'Investigació Biomèdica Sant Pau) ;
Martin Broto, Javier (Hospital Universitario Fundación Jiménez Díaz) ;
Merimsky, Ofer (Unit of Soft Tissue and Bone Oncology. Division of Oncology. Tel-Aviv Medical Center affiliated with Sackler School of Medicine. Tel Aviv University) ;
Merriam, Priscilla (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ;
Miceli, Rosalba (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Mir, Olivier (Sarcoma Group. Gustave Roussy) ;
Molinari, Massimo (University of Pittsburgh Medical Center. Thomas Starzl Transplant Institute) ;
Montemurro, Michael (Oncology. CHUV Lausanne) ;
Oldani, Graziano (Division of Abdominal Surgery. University Hospitals of Geneva) ;
Palmerini, Emanuela (Chemotherapy Unit. IRCCS Istituto Ortopedico Rizzoli) ;
Pantaleo, Maria Abbondanza. (Division of Oncology. IRCCS Azienda Ospedaliero-Universitaria di Bologna) ;
Patel, Sapna Pradyuman (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ;
Piperno-Neumann, Sophie (Department of Medical Oncology. Institut Curie) ;
Raut, Chandrajit Premanand (Dana Farber Cancer Center. Harvard Medical School) ;
Ravi, Vinod (Sarcoma Center. The University of Texas M.D. Anderson Cancer Center) ;
Razak, Albiruni Ryan Abdul (Princess Margaret Cancer Centre and Sinai Healthcare System & Faculty of Medicine. University of Toronto) ;
Reichardt, Peter (Helios Klinikum Berlin-Buch. Department of Oncology and Palliative Care) ;
Rubin, Brian P. (Robert J. Tomsich Pathology and Laboratory Medicine Institute. Cleveland Clinic) ;
Rutkowski, Piotr (Maria Sklodowska-Curie National Research Institute of Oncology. Department of Soft Tissue/Bone Sarcoma and Melanoma) ;
Safwat, Akmal Ahmed (Aarhus University Hospital (Aarhus, Dinamarca)) ;
Sangalli, Claudia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Sapisochin, Gonzalo (Multi-Organ Transplant and HPB Surgical Oncology. Division of General Surgery. Department of Surgery. University of Toronto) ;
Sbaraglia, Marta (Department of Pathology. Azienda Ospedaliera Università Padova) ;
Scheipl, Susanne (Department of Orthopaedics and Trauma. Medical University of Graz) ;
Schöffski, Patrick (Leuven Cancer Institute) ;
Strauss, Dirk Cornelius (Department of Surgery. The Royal Marsden Hospital and The Institute of Cancer Research) ;
Strauss, Sandra J. (University College London Hospital) ;
Sundby Hall, Kirsten (Department of Oncology. Oslo University Hospital. The Norwegian Radium Hospital) ;
Tap, William D. (Department of Medicine. Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College) ;
Trama, Annalisa (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Tweddle, A. (Palliative Care. The Royal Marsden Hospital and The Institute of Cancer Research London) ;
van der Graaf, Winette T.A. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ;
van de Sande, Michiel (Department of Orthopedic Surgery Bone and Soft Tissue Tumor Unit. Leiden University Medical Center) ;
Van Houdt, Winan (Sarcoma and Melanoma Unit. The Netherlands Cancer Institute) ;
van Oortmerssen, Gerard (Co-Chair of Sarcoma Patients EuroNet (SPAEN). Woelfersheim. Germany & Chairman of the Dutch organisation for sarcoma patients (Patiëntenplatform Sarcomen). Guest researcher at Leiden University (Leiden Institute for Advanced Computer Science). Leiden University) ;
Wagner, Andrew J. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica). Department of Medical Oncology) ;
Wartenberg, Markus (Chair of the Board of Directors of Sarcoma Patients EuroNet (SPAEN). Sarcoma Patients EuroNet (SPAEN)) ;
Wood, J. (The Royal Marsden NHS Foundation Trust) ;
Zaffaroni, Nadia (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Zimmermann, Camilla (Department of Supportive Care. Princess Margaret Cancer Centre and Division of Palliative Medicine. Department of Medicine. University of Toronto) ;
Casali, Paolo Giovanni (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia)) ;
Dei Tos, Angelo (Department of Pathology. Azienda Ospedaliera Università Padova) ;
Gronchi, Alessandro (Fondazione IRCCS Istituto Nazionale dei Tumori (Milà, Itàlia))
Epithelioid hemangioendothelioma (EHE) is an ultra-rare, translocated, vascular sarcoma. EHE clinical behavior is variable, ranging from that of a low-grade malignancy to that of a high-grade sarcoma and it is marked by a high propensity for systemic involvement. [...]
2021 - 10.1016/j.esmoop.2021.100170
ESMO open, Vol. 6 Núm. 3 (june 2021) , p. 100170
|
|
|
6.
|
|
38 p, 310.7 KB |
The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome : analysis of high-throughput epigenetic and gene expression studies
/
Malato, João (Universidade de Lisboa) ;
Sotzny, Franziska (Humboldt-Universität zu Berlin) ;
Bauer, Sandra (Charité - Universitätsmedizin Berlin) ;
Freitag, Helma (Charité - Universitätsmedizin Berlin) ;
Fonseca, André (Universidade do Algarve) ;
Grabowska, Anna D. (Medical University of Warsaw) ;
Graça, Luís (Universidade de Lisboa) ;
Cordeiro, Clara (Universidade do Algarve) ;
Nacul, Luís (British Columbia Women's Hospital and Health Centre (Canada)) ;
Lacerda, Eliana (London School of Hygiene & Tropical Medicine) ;
Castro-Marrero, Jesús (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Scheibenbogen, Carmen (Charité - Universitätsmedizin Berlin) ;
Westermeier, Francisco (Universidad Bernardo O'Higgins (Xile)) ;
Sepúlveda, Nuno (London School of Hygiene & Tropical Medicine) ;
Universitat Autònoma de Barcelona
Patients affected by Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) show specific epigenetic and gene expression signatures of the disease. However, it is unknown whether these signatures include abnormal levels of the human angiotensin-converting enzymes, ACE and ACE2, the latter being the main receptor described for the host-cell invasion by SARS-CoV-2. [...]
2021 - 10.1101/2021.03.23.21254175
medRxiv, april 2021
|
|
|
7.
|
|
11 p, 764.7 KB |
The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in myalgic encephalomyelitis/chronic fatigue syndrome : A meta-analysis of public DNA methylation and gene expression data
/
Malato, João (Universidade de Lisboa) ;
Sotzny, Franziska (Charité - Universitätsmedizin Berlin) ;
Bauer, Sandra (Charité - Universitätsmedizin Berlin) ;
Freitag, Helma (Charité - Universitätsmedizin Berlin) ;
Fonseca, André (Universidade do Algarve) ;
Grabowska, Anna D. (Medical University of Warsaw) ;
Graça, Luís (Universidade de Lisboa) ;
Cordeiro, Clara (Universidade do Algarve) ;
Nacul, Luís (British Columbia Women's Hospital) ;
Lacerda, Eliana (London School of Hygiene & Tropical Medicine) ;
Castro-Marrero, Jesús (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Scheibenbogen, Carmen (Charité - Universitätsmedizin Berlin) ;
Westermeier, Francisco (Universidad Bernardo O'Higgins) ;
Sepúlveda, Nuno (London School of Hygiene & Tropical Medicine) ;
Universitat Autònoma de Barcelona
People with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) often report a high frequency of viral infections and flu-like symptoms during their disease course. Given that this reporting agrees with different immunological abnormalities and altered gene expression profiles observed in the disease, we aimed at answering whether the expression of the human angiotensin-converting enzyme 2 (ACE2), the major cell entry receptor for SARS-CoV-2, is also altered in these patients. [...]
2021 - 10.1016/j.heliyon.2021.e07665
Heliyon, Vol. 7 (july 2021) , p. e07665
|
|
|
8.
|
|
|
9.
|
|
6 p, 167.9 KB |
Limits for the central production of Θ+ and Ξ−− pentaquarks in 920-GeV pA collisions
/
Abt, Iris (Max-Planck-Institut für Physik) ;
Adams, Mark Raymond (Universität Dortmund. Institut für Physik) ;
Agari, Michaela (Max-Planck-Institut für Kernphysik) ;
Albrecht, Hartwig (DESY (Hamburg, Alemanya)) ;
Aleksandrov, A. (DESY (Zeuthen, Alemanya)) ;
Amaral, Vasco (LIP Coimbra (Portugal)) ;
Amorim, Antonio (LIP Coimbra (Portugal)) ;
Aplin, Steven (DESY (Hamburg, Alemanya)) ;
Aushev, Volodymyr (Ukrainian Academyof Science. Institute for Nuclear Research) ;
Bagaturia, Iuri (DESY (Hamburg, Alemanya)) ;
Balagura, Vladislav (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Bargiotti, Marianne (Università di Bologna. Dipartimento di Fisica) ;
Barsukova, O. (Joint Institute for Nuclear Research Dubna (Dubna, Rússia)) ;
Bastos, Joao Afonso (LIP Coimbra (Portugal)) ;
Batista, Joao Miguel Nobre (LIP Coimbra (Portugal)) ;
Bauer, Christian (Max-Planck-Institut für Kernphysik) ;
Bauer, Thomas S. (NIKHEF (Amsterdam, Països Baixos)) ;
Belkov, Ar (Joint Institute for Nuclear Research Dubna (Dubna, Rússia)) ;
Belkov, Ar. (Joint Institute for Nuclear Research Dubna (Dubna, Rússia)) ;
Belotelov, I. (Joint Institute for Nuclear Research Dubna (Dubna, Rússia)) ;
Bertin, A. (Università di Bologna. Dipartimento di Fisica) ;
Bobchenko, B. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Böcker, M. (Universität Siegen. Fachbereich Physik) ;
Bogatyrev, A. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Bohm, G. (DESY (Zeuthen, Alemanya)) ;
Bräuer, M. (Max-Planck-Institut für Kernphysik) ;
Bruinsma, M. (NIKHEF (Amsterdam, Països Baixos)) ;
Bruschi, M. (Università di Bologna. Dipartimento di Fisica) ;
Buchholz, P. (Universität Siegen. Fachbereich Physik) ;
Buran, T. (University of Oslo. Department of Physics) ;
Carvalho, J. (LIP Coimbra (Portugal)) ;
Conde, P. (Universitat de Barcelona. Facultat de Física) ;
Cruse, C. (Universität Dortmund. Institut für Physik) ;
Dam, M. (Niels Bohr Institutet (Copenhaguen, Dinamarca)) ;
Danielsen, K. M. (University of Oslo. Department of Physics) ;
Danilov, M. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
De Castro, S. (Università di Bologna. Dipartimento di Fisica) ;
Deppe, H. (Universität Heidelberg. Physikalisches Institut) ;
Dong, X. (Institute for High Energy Physics (Beijing, Xina)) ;
Dreis, H. B. (Universität Heidelberg. Physikalisches Institut) ;
Egorytchev, V. (DESY (Hamburg, Alemanya)) ;
Ehret, K. (Universität Dortmund. Institut für Physik) ;
Eisele, F. (Universität Heidelberg. Physikalisches Institut) ;
Emeliyanov, D. (DESY (Hamburg, Alemanya)) ;
Essenov, S. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Fabbri, L. (Università di Bologna. Dipartimento di Fisica) ;
Faccioli, P. (Università di Bologna. Dipartimento di Fisica) ;
Feuerstack-Raible, M. (Universität Heidelberg. Physikalisches Institut) ;
Flammer, J. (DESY (Hamburg, Alemanya)) ;
Fominykh, B. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Funcke, M. (Universität Dortmund. Institut für Physik) ;
Garrido Beltran, Lluís (Universitat de Barcelona. Facultat de Física) ;
Giacobbe, B. (Università di Bologna. Dipartimento di Fisica) ;
Gläß, J. (Universität Mannheim. Lehrstuhl für Informatik V) ;
Goloubkov, D. (DESY (Hamburg, Alemanya)) ;
Golubkov, Y. (DESY (Hamburg, Alemanya)) ;
Golutvin, A. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Golutvin, I. (Joint Institute for Nuclear Research Dubna (Dubna, Rússia)) ;
Gorbounov, I. (DESY (Hamburg, Alemanya)) ;
Gorisek, A. (J. Stefan Institute (Ljubljana, Eslovènia)) ;
Gouchtchine, O. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Goulart, D. C. (University of Cincinnati. Department of Physics) ;
Gradl, S. (Universität Heidelberg. Physikalisches Institut) ;
Gradl, W. (Universität Heidelberg. Physikalisches Institut) ;
Grimaldi, F. (Università di Bologna. Dipartimento di Fisica) ;
Groth-Jensen, J. (Niels Bohr Institutet (Copenhaguen, Dinamarca)) ;
Guilitsky, Yu. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Hansen, J. D. (Niels Bohr Institutet (Copenhaguen, Dinamarca)) ;
Hernandez, J. M. (DESY (Zeuthen, Alemanya)) ;
Hofmann, W. (Max-Planck-Institut für Kernphysik) ;
Hott, T. (Universität Heidelberg. Physikalisches Institut) ;
Hulsbergen, W. (NIKHEF (Amsterdam, Països Baixos)) ;
Husemann, U. (Universität Siegen. Fachbereich Physik) ;
Igonkina, O. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Ispiryan, M. (University of Houston. Department of Physics) ;
Jagla, T. (Max-Planck-Institut für Kernphysik) ;
Jiang, C. (Institute for High Energy Physics (Beijing, Xina)) ;
Kapitza, H. (DESY (Hamburg, Alemanya)) ;
Karabekyan, S. (Universität Rostock. Fachbereich Physik) ;
Karpenko, N. (Joint Institute for Nuclear Research Dubna (Dubna, Rússia)) ;
Keller, S. (Universität Siegen. Fachbereich Physik) ;
Kessler, J. (Universität Heidelberg. Physikalisches Institut) ;
Khasanov, F. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Kiryushin, Yu. (Joint Institute for Nuclear Research Dubna (Dubna, Rússia)) ;
Klinkby, E. (Niels Bohr Institutet (Copenhaguen, Dinamarca)) ;
Knöpfle, K. T. (Max-Planck-Institut für Kernphysik) ;
Kolanoski, H. (Humboldt-Universitätzu Berlin. Institut für Physik) ;
Korpar, S. (J. Stefan Institute (Ljubljana, Eslovènia)) ;
Krauss, C. (Universität Heidelberg. Physikalisches Institut) ;
Kreuzer, P. (DESY (Hamburg, Alemanya)) ;
Krizan, P. (J. Stefan Institute (Ljubljana, Eslovènia)) ;
Krücker, D. (Humboldt-Universitätzu Berlin. Institut für Physik) ;
Kupper, S. (J. Stefan Institute (Ljubljana, Eslovènia)) ;
Kvaratskheliia, T. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Lanyov, A. (Joint Institute for Nuclear Research Dubna (Dubna, Rússia)) ;
Lau, K. (University of Houston. Department of Physics) ;
Lewendel, B. (DESY (Hamburg, Alemanya)) ;
Lohse, T. (Humboldt-Universitätzu Berlin. Institut für Physik) ;
Lomonosov, B. (DESY (Hamburg, Alemanya)) ;
Männer, R. (Universität Mannheim. Lehrstuhl für Informatik V) ;
Masciocchi, S. (DESY (Hamburg, Alemanya)) ;
Massa, I. (Università di Bologna. Dipartimento di Fisica) ;
Matchikhilian, I. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Medin, G. (Humboldt-Universitätzu Berlin. Institut für Physik) ;
Medinnis, M. (DESY (Hamburg, Alemanya)) ;
Mevius, M. (DESY (Hamburg, Alemanya)) ;
Michetti, A. (DESY (Hamburg, Alemanya)) ;
Mikhailov, Yu. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Mizuk, R. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Muresan, R. (Niels Bohr Institutet (Copenhaguen, Dinamarca)) ;
Negodaev, M. (DESY (Hamburg, Alemanya)) ;
Nörenberg, M. (DESY (Hamburg, Alemanya)) ;
Nowak, S. (DESY (Zeuthen, Alemanya)) ;
Nuñez Pardo de Vera, M. T. (DESY (Hamburg, Alemanya)) ;
Ouchrif, M. (NIKHEF (Amsterdam, Països Baixos)) ;
Ould-Saada, F. (University of Oslo. Department of Physics) ;
Padilla, Cristobal (DESY (Hamburg, Alemanya)) ;
Peralta, D. (Universitat de Barcelona. Facultat de Física) ;
Pernack, R. (Universität Rostock. Fachbereich Physik) ;
Pestotnik, R. (J. Stefan Institute (Ljubljana, Eslovènia)) ;
Piccinini, M. (Università di Bologna. Dipartimento di Fisica) ;
Pleier, Marc-Andre (Max-Planck-Institut für Kernphysik) ;
Poli, M. (Università di Bologna. Dipartimento di Fisica) ;
Popov, V. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Pose, A. (DESY (Zeuthen, Alemanya)) ;
Pose, D. (Joint Institute for Nuclear Research Dubna (Dubna, Rússia)) ;
Prystupa, S. (Ukrainian Academyof Science. Institute for Nuclear Research) ;
Pugatch, V. M. (Ukrainian Academyof Science. Institute for Nuclear Research) ;
Pylypchenko, Y. (University of Oslo. Department of Physics) ;
Pyrlik, J. (University of Houston. Department of Physics) ;
Reeves, K. (Max-Planck-Institut für Kernphysik) ;
Reßing, D. (DESY (Hamburg, Alemanya)) ;
Rick, H. (Universität Heidelberg. Physikalisches Institut) ;
Riu, I. (DESY (Hamburg, Alemanya)) ;
Robmann, P. (Universität Zürich. Physik-Institut) ;
Rostovtseva, I. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Rybnikov, V. (DESY (Hamburg, Alemanya)) ;
Sánchez Nieto, Federico (Institut de Física d'Altes Energies) ;
Sbrizzi, A. (NIKHEF (Amsterdam, Països Baixos)) ;
Schmelling, M. (Max-Planck-Institut für Kernphysik) ;
Schmidt, B. (DESY (Hamburg, Alemanya)) ;
Schreiner, A. (DESY (Zeuthen, Alemanya)) ;
Schröder, H. (Universität Rostock. Fachbereich Physik) ;
Schwartz, Alan J. (University of Cincinnati. Department of Physics) ;
Schwarz, Andreas S. (DESY (Hamburg, Alemanya)) ;
Schwenninger, B. (Universität Dortmund. Institut für Physik) ;
Schwingenheuer, B. (Max-Planck-Institut für Kernphysik) ;
Sciacca, F. (Max-Planck-Institut für Kernphysik) ;
Semprini-Cesari, N. (Università di Bologna. Dipartimento di Fisica) ;
Shuvalov, S. (Humboldt-Universitätzu Berlin. Institut für Physik) ;
Silva, L. (LIP Coimbra (Portugal)) ;
Smirnov, K. (DESY (Zeuthen, Alemanya)) ;
Solunin, S. (Joint Institute for Nuclear Research Dubna (Dubna, Rússia)) ;
Somov, A. (DESY (Hamburg, Alemanya)) ;
Somov, S. (DESY (Hamburg, Alemanya)) ;
Sözüer, L. (DESY (Hamburg, Alemanya)) ;
Spengler, J. (Max-Planck-Institut für Kernphysik) ;
Spighi, R. (Università di Bologna. Dipartimento di Fisica) ;
Spiridonov, A. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Stanovnik, A. (J. Stefan Institute (Ljubljana, Eslovènia)) ;
Staric, M. (J. Stefan Institute (Ljubljana, Eslovènia)) ;
Stegmann, C. (Humboldt-Universitätzu Berlin. Institut für Physik) ;
Subramania, H. S. (University of Houston. Department of Physics) ;
Symalla, M. (Universität Dortmund. Institut für Physik) ;
Tikhomirov, I. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Titov, Maxim P. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Tsakov, I. (Institute for Nuclear Research (Sofia, Bulgària)) ;
Uwer, U. (Universität Heidelberg. Physikalisches Institut) ;
Vassiliev, Yu (Ukrainian Academyof Science. Institute for Nuclear Research) ;
Villa, M. (Università di Bologna. Dipartimento di Fisica) ;
Vitale, A. (Università di Bologna. Dipartimento di Fisica) ;
Vukotic, I. (Humboldt-Universitätzu Berlin. Institut für Physik) ;
Wahlberg, H. (Universiteit Utrech) ;
Walenta, A. H. (Universität Siegen. Fachbereich Physik) ;
Walter, M. (DESY (Zeuthen, Alemanya)) ;
Wang, J. J. (Tsinghua University. Institute of Engineering Physics (Beijing, Xina)) ;
Wegener, D. (Universität Dortmund. Institut für Physik) ;
Werthenbach, U. (Universität Siegen. Fachbereich Physik) ;
Wolters, H. (LIP Coimbra (Portugal)) ;
Wurth, R. (DESY (Hamburg, Alemanya)) ;
Wurz, A. (Universität Mannheim. Lehrstuhl für Informatik V) ;
Zaitsev, Yu. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Zavertyaev, M. (Max-Planck-Institut für Kernphysik) ;
Zech, Gunter (Universität Siegen. Fachbereich Physik) ;
Zeuner, T. (DESY (Hamburg, Alemanya)) ;
Zhelezov, A. (Institute of Theoretical and Experimental Physics (Moscou, Rússia)) ;
Zheng, Z. (Institute for High Energy Physics (Beijing, Xina)) ;
Zimmermann, R. (Universität Rostock. Fachbereich Physik) ;
Zivko, T. (J. Stefan Institute (Ljubljana, Eslovènia)) ;
Zoccoli, A. (Università di Bologna. Dipartimento di Fisica) ;
van Eldik, C. (Universität Dortmund. Institut für Physik) ;
Zur Nedden, M (Humboldt-Universitätzu Berlin. Institut für Physik)
We have searched for Θ+(1540) and Ξ−−(1862) pentaquark candidates in proton-inducedreactions on C, Ti, and W targets at midrapidity and s√=41. 6 GeV. In 2×108 inelastic eventswe find no evidence for narrow (σ≈5 MeV) signals in the Θ+→pK0S and Ξ−−→Ξ−π− channels; our 95% C. [...]
2004 - 10.1103/PhysRevLett.93.212003
Physical review letters, Vol. 93, Issue 21 (November 2004) , p. 212003-1-212003-6
|
|
visitant ::
identificació
alerta personal via correu electrònic o subscribiu-vos al 
canal RSS.
